secwatch.observer — SEC 8-K summary
======================================

Issuer:     Bone Biologics Corp (BBLG)
CIK:        0001419554
Form:       8-K
Filed at:   2023-06-16T23:59:59+00:00
Accession:  0001493152-23-021605
Event type: other_material
Sentiment:  negative
Materiality: 0.65
Item codes: 1.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Bone Biologics prices $5M underwritten public offering of 2.5M shares at $1.97/share
--------------------------------------------------------------------------------

- Gross proceeds of approximately $5.0 million from sale of 2,538,071 shares of common stock at $1.97 per share.
- Underwriters granted 45-day over-allotment option to purchase up to 253,807 additional shares.
- Offering expected to close on or about June 16, 2023, subject to customary conditions.
- EF Hutton, division of Benchmark Investments, acting as sole book-running manager.
- Registration statement on Form S-1 (No. 333-271558) declared effective by SEC on June 14, 2023.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1419554/000149315223021605/0001493152-23-021605-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1419554/000149315223021605/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-23-021605

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer